Autologous stem-cell transplantation for solid tumors in adults

Hematology/Oncology Clinics of North America

Volumn 13, Issue 5, 1999, Pages 939-968

  Nieto, Y ^a   Shpall, E J ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; THIOTEPA;

ADVANCED CANCER; AUTOTRANSPLANTATION; BRAIN TUMOR; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; DRUG MEGADOSE; HUMAN; LUNG SMALL CELL CANCER; MELANOMA; NON SEMINOMATOUS GERMINOMA; OVARY CARCINOMA; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SOFT TISSUE SARCOMA; SOLID TUMOR; STEM CELL; STEM CELL TRANSPLANTATION;

EID: 0032834147     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70104-0     Document Type: Article

References (171)

1. M.S. Aapro G. Zulian P. Alberto Phase I and pharmacokinetic study of RP 569876 in a new ethanol-free formulation of Taxotere Ann Oncol 3 suppl 5 1992 208
2. T. Ahmed E. Feldman L. Helson Phase 1–2 trial of high dose thiotepa with autologous bone marrow transplantation and localized radiotherapy for patients with astrocytoma grade III/IV [abstract] Proceedings of the American Society for Cancer Research 31 1990 A1023
3. I.C. Anderson E.J. Shpall D.S. Leslie Elimination of malignant clonogenic breast cancer cells from human bone marrow Cancer Res 15 1989 4659
4. K. Antman L. Ayash A. Elias A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow support in women with measurable advanced breast cancer responding to standard-dose therapy J Clin Oncol 10 1992 102 110
5. I.M. Ariel G.T. Pack Treatment of disseminated melanoma with phenylalanine mustard (melphalan) and autogenous bone marrow transplants Surgery 51 1962 582 591
6. L.J. Ayash A. Elias C. Wheeler Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: A feasibility study J Clin Oncol 12 1994 37 44
7. L.J. Ayash A. Elias G. Schwartz Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: No improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin J Clin Oncol 14 1996 2984 2992
8. L.J. Ayash C. Wheeler D. Fairclough Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer J Clin Oncol 13 1995 2043 2049
9. L. Ayash A. Elias J. Ibrahim High-dose multimodality therapy with autologous stem cell support for stage IIIB breast cancer J Clin Oncol 16 1998 1000 1007
10. G.H. Barker E. Wiltshaw Use of high-dose cisplatin following failure of previous chemotherapy for advanced carcinoma of the ovary Br J Obstet Gynaecol 88 1981 1192 1199
11. HER2/neu-overexpressing metastatic breast cancer J Clin Oncol 14 1996 737 744
12. S.I. Bearman B.A. Overmoyer B.J. Bolwell High-dose chemotherapy with autologous peripheral blood progenitor cell support for primary breast cancer in patients with 4–9 involved axillary lymph nodes Bone Marrow Transplant 20 1997 931 937
13. B.C. Behrens T.C. Hamilton H. Masuda Characteristics of cisdiamminedichloroplatinum (II)-resistant human ovarian cancer cell line and its evaluation of platinum analogues Cancer Res 47 1987 414 418
14. J. Beyer A. Kramar R. Mandanas High-dose chemotherapy as salvage treatment in germ cell tumors: A multivariate analysis of prognostic variables J Clin Oncol 14 1996 2638 2645
15. W.R. Bezwoda L. Seymour R.D. Dansey High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: A randomized trial J Clin Oncol 13 1995 2483 2489
16. W.R. Bezwoda Primary high dose chemotherapy for metastatic breast cancer: Update and analysis of prognostic factors [abstract] Proceedings of the American Society of Clinical Oncology 17 1998 115a
17. J.D. Bitran B. Samuels L. Klein Tandem high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancer Bone Marrow Transplant 17 1996 157 162
18. J.Y. Blay D. Bouhour M. Brunat-Mentigny High dose chemotherapy (VIC) and bone marrow support in advanced sarcomas [abstract] Proceedings of the American Society of Clinical Oncology 13 1994 A1672
19. G. Bonadonna P. Valagussa Adjuvant systemic therapy for resectable breast cancer J Clin Oncol 3 1985 259 275
20. G. Bonadonna M. Zambetti P. Valagussa Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes. Ten-year results JAMA 273 1995 542 547
21. G.J. Bosl R.J. Motzer Testicular germ-cell cancer N Engl J Med 337 1997 242 253
22. E. Bouffet C. Mottolese A. Jouvet Etoposide and thiotepa followed by ABMT (autologous bone marrow transplantation) in children and young adults with high-grade gliomas Eur J Cancer 33 1997 91 95
23. D. Bron T. Philip C. Guglielmi The PARMA international randomized study in relapsed non-Hodgkin's lymphoma. Analysis on the first 153 preincluded patients Exp Hematol 19 1991 546
24. E.R. Broun R. Sridhara G.W. Sledge Tandem autotransplantation for the treatment of metastatic breast cancer J Clin Oncol 13 1995 2050 2055
25. E.R. Broun C.R. Nichols P. Kneebone Long-term outcome of patients with relapsed and refractory germ cell tumors treated with high-dose chemotherapy and autologous bone marrow rescue Ann Intern Med 117 1992 124 128
26. E.R. Broun C.R. Nichols M. Turns Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support Cancer 73 1994 1716 1720
27. E.R. Broun C.R. Nichols R. Mandanas Dose escalation study of high-dose carboplatin and etoposide with autologous bone marrow support in patients with recurrent and refractory germ cell tumors Bone Marrow Transplant 16 1995 353 358
28. E.R. Broun C.R. Nichols G. Tricot High dose carboplatin/VP-16 plus ifosfamide with autologous bone marrow support in the treatment of refractory germ cell tumors Bone Marrow Transplant 7 1991 53 56
29. E.R. Broun C.R. Nichols G. Gize Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer Cancer 79 1997 1605 1610
30. M. Brower D.C. Ihde A. Johnston-Early Treatment of extensive stage small cell bronchogenic carcinoma. Effects of variation in intensity of induction in chemotherapy Am J Med 75 1983 993 1000
31. H. Bruckner R. Wallace High-dose platinum for the treatment of refractory ovarian carcinoma Gynecol Oncol 12 1981 64 67
32. W. Brugger H. Frommhold K. Pressler Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer Semin Oncol 22 suppl 2 1995 3 8
33. P.J. Cagnoni E.J. Shpall S.I. Bearman Paclitaxel-containing high-dose chemotherapy: The University of Colorado experience Semin Oncol 23 suppl 6 1996 43 48
34. P.J. Cagnoni Y. Nieto E.J. Shpall High-dose chemotherapy with autologous progenitor cell support as part of combined modality therapy for inflammatory breast cancer J Clin Oncol 16 1998 1661 1668
35. Cagnoni PJ, Ceriani RL, Cole W, et al: Phase I study of high-dose radioimmunotherapy with 90-Y-hu-BrE-3 followed by autologous stem cell support (ASCS) in patients with metastatic breast cancer. Seventh Conference on Radioimmunodetection and Radioimmunotherapy of Cancer, Princeton, NJ, October 15–17, 1998
36. C. Chevreau J.P. Droz J.L. Pico Early intensified chemotherapy with autologous bone marrow transplantation in first line treatment of poor risk non-seminomatous germ cell tumors Eur Urol 23 1993 213 218
37. B.W. Cooper T.J. Moss A.A. Ross Occult tumor contamination of hematopoietic stem-cell product does not affect clinical outcome of autologous transplantation in patients with metastatic breast cancer J Clin Oncol 16 1998 3509 3517
38. M.A. Cornbleet T.J. McElwain P.J. Kumar Treatment of advanced malignant melanoma with high-dose melphalan and autologous bone marrow transplantation Br J Cancer 61 1990 330 334
39. J. Crown A. Kritz L. Vahdat Rapid administration of multiple cycles of high-dose myelosuppressive chemotherapy in patients with metastatic breast cancer J Clin Oncol 11 1993 1144 1149
40. M. Crump P.E. Goss M. Prince Outcome of extensive evaluation before adjuvant therapy in women with breast cancer and ten or more positive axillary lymph nodes J Clin Oncol 14 1996 66 69
41. Y.H. Datta P.T. Adams W.R. Drobyski Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction J Clin Oncol 12 1994 475 482
42. D.A. Decker D.L. Ahman H.F. Bisel Complete responders to chemotherapy in metastatic breast cancer. Characterization and analysis JAMA 242 1979 2075 2079
43. R.C. Donehower E.K. Rowinsky L.B. Grochow Phase I trial of taxol in patients with advanced cancer Cancer Treatment Reports 71 1987 1171 1177
44. J.H. Doroshow Anthracyclines and anthracenediones B.A. Chabner D.L. Longo Cancer Chemotherapy and Biotherapy ed 2 1996 Lippincott-Raven Philadelphia
45. J.H. Doroshow G. Somlo C. Ahn Prognostic factors predicting progression-free and overall survival in patients with responsive metastatic breast cancer treated with high-dose chemotherapy and bone marrow stem cell reinfusion [abstract] Proceedings of the American Society of Clinical Oncology 14 1995 319
46. F.R. Dunphy G. Spitzer A.U. Buzdar Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support J Clin Oncol 8 1990 1207 1216
47. F.R. Dunphy G. Spitzer J.E. Rossiter Factors predicting long-term survival for metastatic breast cancer patients treated with high-dose chemotherapy and bone marrow support Cancer 73 1994 2157 2167
48. J.P. Eder K. Antman W.P. Peters High dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer J Clin Oncol 4 1986 646 654
49. J.P. Eder A. Elias T.C. Shea A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients J Clin Oncol 8 1990 1239 1245
50. E.A. Eisenhauer W.W. Ten Bokkel Huinink K.D. Swenerton European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: High-dose versus low-dose and long versus short infusion J Clin Oncol 12 1994 2654 2666
51. A.D. Elias L. Ayash E. Frei Intensive combined modality therapy for limited-stage small-cell lung cancer J Natl Cancer Inst 85 1993 559 566
52. A.D. Elias L.J. Ayash C. Wheeler Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support Bone Marrow Transplant 15 1995 373 379
53. J.M. Extra F. Rousseau R. Bruno Phase I and pharmacokinetic study of Taxotere (RP 569876; NSC 628503) given as a short intravenous infusion Cancer Res 53 1993 1037 1042
54. P. Farha G. Spitzer M. Valdivieso High-dose chemotherapy and autologous bone marrow transplantation for the treatment of small-cell lung carcinoma Cancer 52 1983 1351 1355
55. K.K. Fields G.J. Elfenbein J.B. Perkins High versus standard dose chemotherapy for the treatment of breast cancer Ann N Y Acad Sci 770 1995 288 304
56. K.K. Fields G.J. Elfenbein W.L. Trudeau Clinical significance of bone marrow metastases in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation J Clin Oncol 14 1996 1868 1876
57. H.A. Fine K.B.G. Dear J.S. Loeffler Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults Cancer 71 1993 2585 2597
58. J.L. Finlay S. Goldman M.C. Wong Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors J Clin Oncol 14 1996 2495 2503
59. W. Franklin E.J. Shpall P. Archer Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support Breast Cancer Res Treat 41 1996 1 13
60. E. Frei III G.P. Canellos Dose: A critical factor in cancer chemotherapy Am J Med 69 1980 585 594
61. E. Frei III K. Antman B. Teicher Bone marrow autotransplantation for solid tumors—Prospects J Clin Oncol 4 1989 515 526
62. P. Garcia D. Braguer G. Carkes Comparative effects of Taxol and Taxotere on two different human carcinoma cell lines Cancer Chemother Pharmacol 34 1994 335 343
63. R. Garcia-Carbonero M. Hidalgo L. Paz-Ares Patient selection in high-dose chemotherapy trials: Relevance in high-risk breast cancer J Clin Oncol 15 1997 3178 3184
64. F. Ghavimi N.A. Kernan K. Lindsley Autologous bone marrow transplant in recurrent or poor risk rhabdomyosarcoma or undifferentiated sarcoma [abstract] Proceedings of the Annual Meeting of the Association for Cancer Research 33 1992 A1195
65. A.M. Gianni S. Siena M. Bregni Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: Five-year results J Clin Oncol 15 1997 2312 2321
66. W. Goodwin J. Crowley A retrospective comparison of high-dose BCNU with autologous marrow rescue plus radiotherapy vs. IV BCNU plus radiation therapy in high grade gliomas [abstract] Proceedings of the American Society of Clinical Oncology 8 1989 90
67. P.A. Greenberg G.N. Hortobagyi T.L. Smith Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer J Clin Oncol 14 1996 2197 2205
68. A.R. Hanauske D. Degen S.G. Hilsenbeck Effects of Taxotere and Taxol in vitro colony formation of freshly explanted human tumour cells Anticancer Drugs 3 1992 121 124
69. J. Harris M. Morrow L. Norton Malignant tumors of the breast V.T. De Vita S. Hellman S.A. Rosenberg Cancer: Principles and Practice of Oncology ed 5 1997 Lippincott-Raven Philadelphia
70. R. Herzig G. Phillips S. Wolff Treatment of metastatic melanoma with intensive melphalan-BCNU combination chemotherapy and cryopreserved autologous bone marrow transplantation [abstract] Proceedings of the American Society of Clinical Oncology 3 1984 264
71. G.N. Hortobagyi G.P. Bodey A.U. Buzdar Evaluation of high-dose versus standard FAC chemotherapy for advanced breast cancer in protected environment units: A prospective randomized study J Clin Oncol 5 1987 354 364
72. G.N. Hortobagyi A.U. Buzdar R. Champlin Lack of efficacy of adjuvant high-dose tandem combination chemotherapy for high-risk primary breast cancer—A randomized trial [abstract] Proceedings of the American Society of Clinical Oncology 17 1998 123a
73. W. Hryniuk H. Busch The importance of dose intensity in chemotherapy of metastatic breast cancer J Clin Oncol 2 1984 1281 1288
74. W. Hryniuk E. Frei III F.A. Wright A single scale for comparing dose-intensity of all chemotherapy regimens in breast cancer: Summation dose-intensity J Clin Oncol 16 1998 3137 3147
75. W. Hryniuk M.N. Levine Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer J Clin Oncol 4 1986 1162 1170
76. C. Hudis A. Seidman G. Raptis Sequential adjuvant therapy: The Memorial Sloan-Kettering Cancer Center experience Semin Oncol 23 suppl 1 1996 58 64
77. Y. Humblet M. Symann A. Bosly Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: A randomized study J Clin Oncol 5 1987 1864 1873
78. D.C. Ihde E. Glatstein H.I. Pass Small cell lung cancer V.T. De Vita S. Hellman S.A. Rosenberg Cancer: Principles and Practice of Oncology ed 5 1997 Lippincott-Raven Philadelphia
79. I.A. Jaiyesimi A.U. Buzdar G. Hortobagyi Inflammatory breast cancer: A review J Clin Oncol 10 1992 1014 1024
80. D.B. Johnson J.M. Thompson J.A. Corwin Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation J Clin Oncol 5 1987 783 789
81. R.B. Jones E.J. Shpall M. Ross AFM induction chemotherapy followed by intensive alkylating agent consolidation with autologous bone marrow support (ABMS) for advanced breast cancer: Current results Proceedings of the American Society of Clinical Oncology 7 1990 121
82. R.B. Jones E.J. Shpall J. Shogan The Duke AFM program. Intensive induction chemotherapy for metastatic breast cancer Cancer 66 1990 431 436
83. M.S. Kaminski L. Fig K. Zasadny Imaging, dosimetry, and radioimmunotherapy with iodine-131–labeled anti-CD37 antibody in B-cell lymphoma J Clin Oncol 10 1992 1696
84. M.S. Kaminski T. Gribbin J. Estes I-131 antibody for previously untreated follicular lymphoma: Clinical and molecular remissions [abstract] Proceedings of the American Society of Clinical Oncology 17 1998 2a
85. A. Kessinger K. Petersen M. Bishop High dose therapy with autologous hematopoietic stem cell rescue for patients with metastatic soft tissue sarcoma [abstract] Proceedings of the American Society of Clinical Oncology 13 1994 A1674
86. I.F. Khouri M. Keating M. Körbling Transplant-lite: Induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies J Clin Oncol 16 1998 2817 2824
87. E.C. Kohn G. Sarosy A. Bicher Dose intense taxol: High response rate in patients with platinum resistant recurrent ovarian cancer J Natl Cancer Inst 86 1994 18 24
88. D.S. Krause M.J. Fackler C.I. Civin CD34: Structure, biology and clinical utility Blood 87 1996 1 13
89. G.F. Laport G. Grad D.L. Grinblatt High-dose chemotherapy consolidation with autologous stem cell rescue in metastatic breast cancer: A 10-year experience Bone Marrow Transplant 21 1998 127 132
90. M. Legros J. Dauplat J. Fleury High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: Long-term results J Clin Oncol 15 1997 1302 1308
91. L. Levin W.M. Hryniuk Dose-intensity analysis of chemotherapy regimens in ovarian carcinoma J Clin Oncol 5 1987 756 767
92. Y.J. Lidor E.J. Shpall W.P. Peters Synergistic cytotoxicity of different alkylating agents for epithelial ovarian cancer Int J Cancer 49 1991 704 710
93. J. Lister W.B. Rybka A.D. Donnenberg Autologous peripheral blood stem cell transplantation and adoptive immunotherapy with activated natural killer cells in the immediate post-transplant period Clinical Cancer Research 1 1995 607 614
94. J.I. Mayordomo A. Yubero R. Cajal Phase I trial of high-dose paclitaxel in combination with cyclophosphamide, thiotepa and carboplatin with autologous peripheral blood stem cell rescue [abstract] Proceedings of the American Society of Clinical Oncology 16 1997 102a
95. W.P. McGuire How many more nails to seal the coffin of dose intensity? [review] Ann Oncol 8 1997 311 313
96. G.M. Mead International consensus prognostic classification for metastatic germ cell tumors treated with platinum based chemotherapy: Final report of the International Germ Cell Cancer Collaborative Group (IGCCG) [abstract] Proceedings of the American Society of Clinical Oncology 14 1995 235a
97. B.R. Meisenberg M. Ross J.J. Vredenburgh Randomized trial of high-dose chemotherapy with autologous bone marrow support as adjuvant therapy for high-risk multi-node-positive malignant melanoma J Natl Cancer Inst 85 1994 1080 1085
98. R. Mesia C. Sola A. López-Pousa High-dose chemotherapy and autologous bone marrow transplantation in high-grade metastatic sarcomas [Spanish] Rev Clin Esp 194 1994 960 965
99. D.W. Miles H.M. Earl R.L. Souhami Intensive weekly chemotherapy for good-prognosis patients with small-cell lung cancer J Clin Oncol 9 1991 280 285
100. M. Mohr E. Hilgenfeld T. Fietz Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell (PBPC) samples used for hematopoietic rescue after high-dose therapy Clin Cancer Res 5 1999 1035 1040
101. R.J. Motzer S.C. Gulati J.P. Crown High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors Cancer 69 1992 550 556
102. R.J. Motzer M. Mazumdar G.J. Bosl High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: Treatment results and prognostic factors for survival and toxicity J Clin Oncol 14 1996 1098 1105
103. R.J. Motzer M. Mazumdar S.C. Gulati Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors J Natl Cancer Inst 85 1993 1828 1835
104. R.J. Motzer M. Mazumdar D.F. Bajorin High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors J Clin Oncol 15 1997 2546 2552
105. J.E. Neidhart W. Kohler C. Stidley A phase I study of repeated cycles of high-dose cyclophosphamide, etoposide and cisplatin administered without bone marrow transplantation J Clin Oncol 8 1990 1728 1738
106. C.R. Nichols G. Tricot S.D. Williams Dose-intensive chemotherapy in refractory germ cell cancer: A phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation J Clin Oncol 7 1989 932 939
107. C.R. Nichols J. Andersen H.M. Lazarus High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: An Eastern Cooperative Oncology Group protocol J Clin Oncol 10 1992 558 563
108. C.R. Nichols S.D. Williams P.J. Loehrer Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: A Southeastern Cancer Study Group and Southwest Oncology Group protocol J Clin Oncol 9 1991 1163 1172
109. Y. Nieto P.J. Cagnoni X. Xu Predictive model for relapse after high-dose chemotherapy with peripheral blood progenitor cell support for high-risk primary breast cancer [abstract] Proceedings of the American Society of Clinical Oncology 17 1998 119a
110. Nieto Y, Cagnoni, Shpall EJ, et al: Prospective phase II study of high-dose chemotherapy with autologous stem cell transplant for patients with Stage IV breast cancer with minimal metastases. Clin Cancer Res, in press.
111. K. Osterlind H.H. Hansen M. Hansen Long-term disease-free survival in small-cell carcinoma of the lung: A study of clinical determinants J Clin Oncol 4 1986 1307 1313
112. R.F. Ozols Treatment of ovarian cancer: Current status Semin Oncol 21 1994 1 9
113. R.F. Ozols Y. Otschega C. Myers High-dose cisplatin in hypertonic saline in refractory ovarian cancer J Clin Oncol 3 1985 1246 1250
114. HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu–overexpressing metastatic breast cancer refractory to chemotherapy treatment J Clin Oncol 16 1998 2659 2671
115. W.P. Peters W.D. Henner R.C. Bast Novel toxicities associated with high dose combination alkylating agents in autologous bone marrow support K.A. Dicke G. Spitzer A.R. Zander Autologous Bone Marrow Transplantation: Proceedings of the First International Symposium 1986 University of Texas Cancer Center, MD Anderson Hospital Houston, TX 231 235
116. W.P. Peters J.P. Eder W.D. Henner High-dose combination chemotherapy with autologous bone marrow support: A phase I trial J Clin Oncol 4 1986 646 654
117. W.P. Peters E.J. Shpall R.B. Jones High-dose combination chemotherapy with bone marrow support as initial treatment for metastatic breast cancer J Clin Oncol 6 1988 1368 1376
118. W.P. Peters R.B. Jones J. Vredenburgh A large, prospective, randomized trial of high-dose combination alkylating agents (CPB) with autologous cellular support as consolidation for patients with metastatic breast cancer achieving complete remission after intensive doxorubicin-based induction therapy (AFM) [abstract] Proceedings of the American Society of Clinical Oncology 15 1996 121a
119. W.P. Peters M. Ross J.J. Vredenburgh High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer J Clin Oncol 11 1993 1132 1143
120. T. Philip F. Chauvin D. Bron PARMA international protocol: Pilot study on 50 patients and preliminary analysis of the ongoing randomized study (62 patients) Ann Oncol 2 suppl 1991 57 64
121. T. Philip C. Guglielmi A. Hagenbeek Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma N Engl J Med 333 1995 1540 1545
122. G.L. Phillips J.W. Fay G.P. Herzig A phase I-II study; intensive BCNU (1,3-bis (2-chloroethyl)-1-nitrosourea, NSC 409962) and autologous bone marrow transplantation for refractory cancer Cancer 52 1982 1792 1802
123. G.L. Phillips S.N. Wolff J.W. Fay Intensive BCNU chemotherapy and autologous bone marrow transplantation for malignant glioma J Clin Oncol 4 1986 639 645
124. J.P. Pignon R. Arriagada D.C. Ihde A meta-analysis of thoracic radiotherapy for small-cell lung cancer N Engl J Med 327 1992 1618 1624
125. T.J. Powles I.E. Smith H.T. Ford Failure of chemotherapy to prolong survival in a group of patients with metastatic breast cancer Lancet 1 1980 580 582
126. O. Press J. Eary J. Appelbaum Radiolabeled antibody therapy of B-cell lymphoma with autologous bone marrow support N Engl J Med 329 1993 1219
127. Z.U. Rahman D.K. Frye A.U. Buzdar Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer J Clin Oncol 15 1997 3171 3177
128. E. Raymond A. Hanauske S. Faivre Effects of prolonged versus short-term exposure paclitaxel on human tumor colony-forming units Anticancer Drugs 8 1997 379 385
129. S. Rodenhuis A. Westermann M.J. Holtkamp Feasibility of multiple courses of high-dose cyclophosphamide, thiotepa, and carboplatin for breast cancer or germ cell cancer J Clin Oncol 14 1996 1473 1483
130. S. Rodenhuis D.J. Richel E. van der Wall Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement Lancet 352 1998 515 521
131. A.A. Ross B.W. Cooper H.M. Lazarus Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques Blood 82 1993 2605
132. B.J. Roth D.H. Johnson L.H. Einhorn Randomized study of cyclophosphamide, doxorubicin, and vincristine, versus etoposide and cisplatin, versus alternation of these two regimens in extensive small cell lung cancer. A phase III trial of the Southeastern Cancer Study Group J Clin Oncol 10 1992 282 291
133. A. Schoenfeld K.H. Kruger J. Gomm The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19 Eur J Cancer 33 1997 854 861
134. C.L. Shapiro L. Ayash I.J. Webb Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patients J Clin Oncol 15 1997 674 683
135. J.C. Sharp A. Kessinger S. Mann Detection and clinical significance of minimal tumor cell contamination of peripheral blood stem cell harvests International Journal of Cell Cloning 10 suppl 1 1992 92 94
136. T.C. Shea K.H. Antman J.P. Eder Malignant melanoma: Treatment with high-dose combination alkylating agent chemotherapy and autologous bone marrow support Arch Dermatol 124 1988 878 884
137. E.J. Shpall R.B. Jones R.C. Bast 4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: A phase I trial J Clin Oncol 9 1991 85 93
138. E.J. Shpall R.C. Bast W.T. Joines Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation Bone Marrow Transplant 7 1991 145 151
139. E.J. Shpall R.B. Jones S.I. Bearman Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment J Clin Oncol 12 1994 28 36
140. Shpall EJ, Bearman SI, Cagnoni PJ, et al: Long-term follow-up of CD34-positive hematopoietic progenitor cell support for breast cancer patients receiving high-dose chemotherapy. J Clin Oncol, in press
141. E.J. Shpall D. Clarke-Pearson T. Soper High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer Gynecol Oncol 38 1990 386 391
142. E.J. Shpall R.B. Jones S.I. Bearman Future strategies for the treatment of advanced epithelial ovarian cancer using high-dose chemotherapy and autologous bone marrow support Gynecol Oncol 54 1994 357 361
143. W. Siegert J. Beyer High-dose chemotherapy and ASCR of patients with relapsed or refractory germ cell tumors: Long-term follow-up Bone Marrow Transplant 18 suppl 1 1996 S60
144. W. Siegert J. Beyer I. Strohscheer High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: A phase I/II study J Clin Oncol 12 1994 1223 1231
145. D.J. Slamon G. Clark S. Wong Human breast cancer: Correlation of relapse and survival with amplification of the Her-2/neu oncogene Science 2235 1987 177 181
146. TM (humanized anti-her2 antibody) to first line chemotherapy for her2 overexpressing metastatic breast cancer markedly increases anticancer activity: A randomized, multinational controlled phase III trial [abstract] Proceedings of the American Society of Clinical Oncology 17 1998 98a
147. R.L. Souhami P.G. Harper D. Linch High-dose cyclophosphamide with autologous bone marrow transplantation for small-cell lung carcinoma of the bronchus Cancer Chemother Pharmacol 10 1983 205 207
148. R.L. Souhami G. Finn W.M. Gregory High-dose cyclophosphamide in small-cell carcinoma of the lung J Clin Oncol 3 1985 958 963
149. R.L. Souhami H.T. Hajichristou D.W. Miles Intensive chemotherapy with autologous bone marrow transplantation for small-cell lung cancer Cancer Chemother Pharmacol 24 1989 321 325
150. G. Somlo J.H. Doroshow S.J. Forman High-dose chemotherapy and stem-cell rescue in the treatment of high-risk breast cancer: Prognostic indicators of progression-free and overall survival J Clin Oncol 15 1997 2882 2893
151. G. Spitzer P. Farha M. Valdivieso High-dose intensification therapy with autologous bone marrow support for limited small-cell bronchogenic carcinoma J Clin Oncol 4 1986 4 13
152. R.M. Steinman The dendritic cell system and its role in immunogenicity Annu Rev Immunol 9 1991 271 296
153. S.M. Stemmer P.J. Cagnoni E.J. Shpall High-dose paclitaxel, cyclophosphamide, and cisplatin with autologous hematopoietic progenitor-cell support: A phase I trial J Clin Oncol 14 1996 1463 1472
154. P.J. Stiff R.S. McKenzie D.S. Alberts Phase I clinical and pharmacokinetic study of high-dose mitoxantrone combined with carboplatin, cyclophosphamide, and autologous bone marrow rescue: High response rate for refractory ovarian carcinoma J Clin Oncol 12 1994 176 183
155. P.J. Stiff R. Bayer M. Camarda A phase II trial of high-dose mitoxantrone, carboplatin and cyclophosphamide with autologous bone marrow rescue for recurrent epithelial ovarian carcinoma: Analysis of risk factors for clinical outcome Gynecol Oncol 57 1995 278 285
156. P.J. Stiff R. Bayer C. Kerger High dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: A multivariate analysis for 100 consecutively treated patients J Clin Oncol 15 1997 1309 1317
157. T. Takvorian L.M. Parker F.H. Hochberg Autologous bone marrow transplantation: Host effects of high-dose BCNU J Clin Oncol 1 1983 610 620
158. I.F. Tannock N.F. Boyd G. DeBoer A randomized trial of two doses of cyclophosphamide, methotrexate and fluorouracil for patients with metastatic breast cancer J Clin Oncol 6 1988 1377 1387
159. B.A. Teicher G. Ara S.R. Keyes Acute in vivo resistance in high-dose therapy Clinical Cancer Research 4 1998 483 491
160. D. Thatcher M. Lind G. Morgenstern High-dose double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma Cancer 63 1989 1296 1302
161. F. Thomas R. Arriagada M. Spielmann Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy Cancer 76 1995 2286 2290
162. N.T. Ueno G. Rondón N.Q. Mirza Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer J Clin Oncol 16 1998 986 993
163. T. Umiel T.J. Moss B. Cooper The prognostic value of bone marrow micrometastases in stage II/III breast cancer patients undergoing autologous transplant (ABMT) therapy [abstract] Proceedings of the American Society of Clinical Oncology 17 1998 79a
164. P. Viens G. Gravis D. Blaise High dose chemotherapy with bone marrow rescue for patients with FIGO stage III or IV common epithelial ovarian carcinoma responding to first line treatment [abstract] Proceedings of the Annual Meeting of the American Society of Clinical Oncology 14 1995 A811
165. P. Viens D. Maraninchi M. Legros High dose melphalan and autologous marrow rescue in advanced epithelial ovarian carcinomas: A retrospective analysis of 35 patients treated in France Bone Marrow Transplant 5 1990 227 233
166. J. Vredenburgh O. Silva G. Broadwater The significance of tumor contamination in the bone marrow from high-risk primary breast cancer patients treated with high-dose chemotherapy and hematopoietic support Biology of Blood and Marrow Transplantation 3 1997 91 97
167. J.J. Vredenburgh A. Hussein P. Rubin High-dose chemotherapy and immunomagnetically purged peripheral blood progenitor cells and bone marrow for metastatic breast carcinoma [abstract] Proceedings of the American Society of Clinical Oncology 15 1996 339
168. S.F. Williams J.D. Bitran L. Kaminer A phase I-II study of bialkylator chemotherapy, high-dose thiotepa, and cyclophosphamide with autologous bone marrow reinfusion in patients with advanced cancer J Clin Oncol 5 1990 260 265
169. S.F. Williams T. Gilewski R. Mick High-dose consolidation therapy with autologous stem cell rescue in stage IV breast cancer: Follow-up report J Clin Oncol 10 1992 1743 1747
170. S.N. Wolff R.H. Herzig J.W. Fay High-dose thiotepa with autologous bone marrow transplantation for metastatic malignant melanoma: Results of phase I and II studies of the North American Bone Marrow Transplantation Group J Clin Oncol 7 1989 245 249
171. W.C. Wood D.R. Budman A.H. Korzun Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma N Engl J Med 330 1994 1253 1259